Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Jul 21, 2014; 20(27): 9017-9025
Published online Jul 21, 2014. doi: 10.3748/wjg.v20.i27.9017
Published online Jul 21, 2014. doi: 10.3748/wjg.v20.i27.9017
Gut flora | Lumen factors | Hepatic factors | Host |
Bacterial diversity and function | Barrier integrity | Enzyme heterogeneity (e.g., alcohol dehydrogenase) | Diet |
Mucosal or lumen associated | Immune defense | Liver disease | Medications |
Location | Mucosal disease (e.g., celiac, crohns) | Cirrhosis and porto-systemic shunting | Co-morbid conditions (e.g., diabetes) |
(e.g., small bowel, right colon) | |||
Transit time | Age, gender, body mass index |
- Citation: Solga SF. Breath volatile organic compounds for the gut-fatty liver axis: Promise, peril, and path forward. World J Gastroenterol 2014; 20(27): 9017-9025
- URL: https://www.wjgnet.com/1007-9327/full/v20/i27/9017.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i27.9017